patients with axillary node disease were treated on three different protocols : cyclophosphamide + methotrexate + fluoro-uracil + vincristine + prednisone ( cmfvp ) , cyclophosphamide + methotrexate + fluoro-uracil ( cmf ) , and cmf + immunotherapy with methanol extract residue of bcg ( cmf + mer ) .
C0055987
cmfvp
C0016360
cmf